In order to ensure a safe and optimal treatment implementation with transcranial pulse stimulation, we must first determine whether this therapy option is suitable for the patient.
About 65% of the affected dementia patients within our population suffer from Alzheimer’s dementia, which thus accounts for by far the largest proportion of dementia diseases. But even with Alzheimer’s dementia, there are often mixed forms, such as Alzheimer’s dementia combined with vascular dementia, body-Lewy dementia or frontotemporal dementia, as well as many other forms of dementia, which include about 50 different variants. In addition, many patients suffer from dementia as well as Parkinson’s disease or depression. And finally, it should be noted that, according to the current state of science, a definite or final diagnosis can only be made “post mortem”, i.e. after death.
Therefore, we can only decide individually whether the patient may be treated with Transcranial Pulse Stimulation after a detailed assessment of the neurological findings and in a personal conversation with the patient and his/her relatives as well as neurological tests. The personal expertise of Prof. Dr. med. Musa Citak as an experienced user and expert in regenerative medicine is therefore the first prerequisite for treatment with this Alzheimer’s dementia therapy.